6Nathanson SD,Zarbo RJ,Wachna DL,et al.Microvessels that predict axillay lymph node metastases in patients with breast cancer[J].Arch Surg,2000,135(5):586.
7Coskun U,Akyürek N,Dursun A,et al.Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma[J].J Surg Res,2009,21(3):690.
8Padera TP,Kadambi A,di Tomaso E,et al.Lymphatic metastasis in the absence of functional intratumor lymphatic[J].Science,2002,296(5574):1883.
9Banerji S,Ni J,Wang SX,et al.LYVE-1,a new homologue of the CD44 glycoprotein,is a lymph-specific receptor for hyaluronan[J].J Cell Biol,1999,144(4):789.
10Jackson DG,Prevo R,Clasper S,et al.LYVE-1,the lymphatic system and tumor lymphangiogenesis[J].Trends Immunol,2001,22(6):317.
1Wang Q, Hu D F, Rui Y, et al. Prognosis value of HIF- l alpha expression in patients with non-small cell hmg cancer[ J ]. (J-erie, 2014,541 ( 2 ) : 69-74.
2Sun G, Hu W, Lu Y, et al. A meta-analysis of HIF- l alpha and esophageal squamous cell carcinoma (ESCC) risk[J]. Pathol Oncol Res, 2013,19(4) :685-693.
3Luezak M W, Roszak A, Pawlik P, et al. Increased ex- pression of tlIF-IA and its implication in the hypoxia pathway in primary advanced uterinecervical carcinoma[ J]. Oncol Rep,2011,26(5)1259-1264.
4Qiang L, Wu T,Zhang H W,ef al. HIF-1 alpha is criti-cal for hypoxia- mediated maintenance of glioblastomastem cells by activating Notch signaling pathway [ J ]. CellDeath Differ, 2012,19(2) :284-294.
5Jochmanova I,Zelinka T,Widimsky J, Jr.,et al. HIFsignaling pathway in pheochromocytoma and other neuro-endocrine tumors [ J ]. Physiol Res, 2014,63 ( Suppl 2):S251-S262.
6Gong K, Zhang N, Zhang K, et al. The relationship oferythropoietin overexpression with von Hippel-Lindautumour suppressor gene mutations between hypoxia- induc-ible factor-1 alpha and -2alpha in sporadic clear cell renalcarcinoma[ J]. Int J Mol Med, 2010,26(6) :907-912.
7Zhou J, Schmid T, Schnitzer S, et al. Tumor hypoxia andcancer progression[ J]. Cancer Lett, 2006,237(1) : 10-21.
8Rohwer N,Cramer T. Hypoxia-mediated drug resistance :novel insights on the functional interaction of HIFs andcell death pathways [ J ]. Drug Resist Updat,2011 , 14(3):191-201.
9Bagnail J, Leedale J, Taylor S E, ef al. Tight control ofhypoxia-inducible factor-alpha transient dynamics is es-sential for cell survival in hypoxia [ J ]. J Biol Chem,2014,289(9) ;5549-5564.
10Fandrey J, Gassmann M. Oxygen sensing and the activa-tion of the hypoxia inducible factor 1 ( HIF-1) -invited ar-ticle [J].Adv Exp Med Biol, 2009,648:197-206.
